ADAPTIVE BIOTECHNOLOGIES CORPORATION
ADPTLoading price...
Overview
Previous Close17.23
Open17.60
Ask22.52
Bid14.16
Day's Range17.53 - 19.74
52 Week Range9.95 - 20.76
PE Ratio(TTM)--
Market Cap3.08B
Volume3.92M
Avg. Volume2.28M
12 Months Earnings-49.68M
12 Months Revenue295.41M
Performance
ABSCAGR
| YTD | 1 Month | 3 Months | 1 Year | 2 Years | 5 Years | 10 Years | |
|---|---|---|---|---|---|---|---|
| No results to display | |||||||
Profit/Loss
| PARTICULARS | TTM | 2025 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Operating Revenue | 295.41M | 276.98M | 205.22M | 178.96M | 170.28M | 185.31M |
| Cost of Revenue | 73.09M | 71.36M | 69.69M | 72.08M | 75.55M | 57.91M |
| Gross Profit | 222.32M | 205.62M | 135.53M | 106.88M | 94.72M | 127.40M |
| Operating Expenses | 269.04M | 262.74M | 256.63M | 262.22M | 296.33M | 327.58M |
| Profit after Tax (Net Income) | -49.68M | -59.50M | -121.23M | -159.49M | -225.25M | -200.19M |
Company Profile
Sector: Healthcare
Industry: Diagnostics & Research
HQ Location: Seattle, United States
Website: https://www.adaptivebiotech.com
Co-Founder, CEO & Chairman: Mr. Chad M. Robins M.B.A.
Employees: 624
About Company:
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.